Tonix Pharmaceuticals Holding Stock Price on December 16, 2024
| TNXP Stock | USD 0.34 0.03 8.11% |
Below is the normalized historical share price chart for Tonix Pharmaceuticals Holding extending back to February 03, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tonix Pharmaceuticals stands at 0.34, as last reported on the 30th of December, with the highest price reaching 0.35 and the lowest price hitting 0.31 during the day.
If you're considering investing in Tonix Stock, it is important to understand the factors that can impact its price. Tonix Pharmaceuticals is abnormally volatile given 3 months investment horizon. Tonix Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14% return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.75% are justified by taking the suggested risk. Use Tonix Pharmaceuticals Coefficient Of Variation of 684.89, risk adjusted performance of 0.126, and Semi Deviation of 8.71 to evaluate company specific risk that cannot be diversified away.
At this time, Tonix Pharmaceuticals' Common Stock Total Equity is relatively stable compared to the past year. As of 12/30/2024, Common Stock Shares Outstanding is likely to grow to about 559.1 K, though Sale Purchase Of Stock is likely to grow to (13.3 M). . At this time, Tonix Pharmaceuticals' Price Book Value Ratio is relatively stable compared to the past year. As of 12/30/2024, Price To Book Ratio is likely to grow to 0.07, while Price Earnings To Growth Ratio is likely to drop 0.0008. Tonix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of May 2012 | 200 Day MA 2.1906 | 50 Day MA 0.218 | Beta 2.077 |
Tonix |
Sharpe Ratio = 0.1431
| Best Portfolio | Best Equity | |||
| Good Returns | TNXP | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.21 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.75 actual daily | 54 54% of assets have lower returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Tonix Pharmaceuticals is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tonix Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.8502 | Enterprise Value Ebitda 0.9408 | Price Sales 5.0647 | Shares Float 22 M | Wall Street Target Price 5.8333 |
Related Headline
Acasti Pharma Headline on 25th of October 2024
Acasti Pharma changes name to Grace Therapeutics by seekingalpha.com
Acasti Pharma changes its name to Grace Therapeutics, set to trade as GRCE on Nasdaq starting October 28, 2024.
Tonix Pharmaceuticals Valuation on December 16, 2024
It is possible to determine the worth of Tonix Pharmaceuticals on a given historical date. On December 16, 2024 Tonix was worth 0.3 at the beginning of the trading date compared to the closed value of 0.53. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Tonix Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Tonix Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tonix Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Tonix Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.24 | 0.25 | 0.22 | 0.24 | 48,099,195 | |
12/16/2024 | 0.30 | 0.56 | 0.28 | 0.53 | 1,189,338,752 |
| 0.33 | 0.33 | 0.32 | 0.33 | 1,013,111,507 |
| Backtest Tonix Pharmaceuticals | | | Tonix Pharmaceuticals History | | | Tonix Pharmaceuticals Valuation | Previous | Next |
Tonix Pharmaceuticals Trading Date Momentum on December 16, 2024
| On December 17 2024 Tonix Pharmaceuticals Holding was traded for 0.33 at the closing time. The top price for the day was 0.33 and the lowest listed price was 0.32 . The trading volume for the day was 1 B. The trading history from December 17, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 37.74% . The trading price change against the current closing price is 28.30% . |
Tonix Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Tonix Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Tonix Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Tonix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Tonix Pharmaceuticals Stock history
Tonix Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tonix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tonix Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tonix Pharmaceuticals stock prices may prove useful in developing a viable investing in Tonix Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 532.5 K | 559.1 K | |
| Net Loss | -105.2 M | -99.9 M |
Tonix Pharmaceuticals Quarterly Net Working Capital |
|
Tonix Pharmaceuticals Stock Technical Analysis
Tonix Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Tonix Pharmaceuticals Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
Tonix Pharmaceuticals Holding cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Tonix Pharmaceuticals December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Tonix Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tonix Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Tonix Pharmaceuticals stock market strength indicators, traders can identify Tonix Pharmaceuticals Holding entry and exit signals to maximize returns
Tonix Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tonix Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Tonix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tonix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.126 | |||
| Jensen Alpha | 2.68 | |||
| Total Risk Alpha | 2.21 | |||
| Sortino Ratio | 0.1924 | |||
| Treynor Ratio | 1.03 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Tonix Stock Analysis
When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.